There’s nothing quite like settling in for a long train journey with a tonne of snacks, books and unlimited window views. So, if you’ve got the patience, then you’ll be wanting to tick the ...
VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announced the results of a large-scale study which shows that its Nu.Q®NETs H3.1 biomarker is an ...
In older ESRD patients on renal replacement therapy (RRT) with frailty phenotype, the risk of mortality at 1 year is three-times higher compared with ESRD patients without frailty phenotype.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results